Doctor profile · Federal record

Dr. Rochelle Robicheaux Metoyer, M.D.

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Ruston, LA

  • NPI 1750575890
  • Accepts Medicare
  • MIPS 77.3 / 100 · 2023
  • 22 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1200 S Farmerville St
Ruston, LA 712705941
(318) 255-3690
fax (318) 251-6116

Credentials & registration

NPPES · NUCC
NPI registered
August 2007 — 19 yrs on file
Profile last updated
June 13, 2014
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Louisiana #MD.200719
Medicaid (2)
MS #02778886 · LA #1067695

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750575890. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
105,632
Distinct HCPCS
10
Medicare allowed
$3,687,765
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 43,650 70 $41
J1602 Injection, golimumab, 1 mg, for intravenous use 28,020 34 $13
J0897 Injection, denosumab, 1 mg 9,122 99 $23
J9312 Injection, rituximab, 10 mg 5,050 16 $80
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 5,028 31 $35
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,350 21 $33
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 3,802 12 $41
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 1,600 13 $22
99215 Established patient office or other outpatient visit, 40-54 minutes 1,279 483 $166
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 634 125 $57

In context: peer comparison

Among 1 peers in Ruston Rheumatology Physician, average services per provider: 3,912. This provider delivers 27× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$796
Transactions
34
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Amgen INC. 10 $168.31
Genzyme Corporation 1 $124.99
Janssen Biotech, INC. 2 $114.89
Novartis Pharmaceuticals Corporation 4 $86.65
Pfizer INC. 4 $77.43
Abbvie INC. 3 $58.87
Sandoz INC. 2 $41.41
Merck Sharp & Dohme LLC 2 $28.51
Organon LLC 2 $25.79
Aurinia Pharma U.S., INC. 1 $18.79
Ucb, INC. 1 $18.61
Exact Sciences Corporation 1 $17.13
Celltrion USA INC. 1 $14.96

By nature of payment

Food and Beverage
$682
Education
$114

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,187
Patients
1,206
Total drug cost
$233,092
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 499 188 $28,706
Prednisone Generic 478 184 $4,138
Methotrexate (Methotrexate Sodium) Brand 428 133 $11,154
Leflunomide Generic 330 115 $18,673
Duloxetine Hcl Generic 270 101 $6,580
Sulfasalazine Generic 270 99 $8,540
Gabapentin Generic 263 90 $3,847
Tizanidine Hcl Generic 120 61 $1,617
Celecoxib Generic 119 53 $2,992
Alendronate Sodium Generic 92 30 $874

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Rochelle Robicheaux Metoyer's medical specialty?
Dr. Rochelle Robicheaux Metoyer practices Rheumatology Physician in Ruston, LA.
Where does Dr. Rochelle Robicheaux Metoyer practice?
Dr. Rochelle Robicheaux Metoyer practices at 1200 S Farmerville St, Ruston, LA 712705941. Office phone: 3182553690.
What is Dr. Rochelle Robicheaux Metoyer's NPI?
Dr. Rochelle Robicheaux Metoyer's National Provider Identifier (NPI) is 1750575890, issued by NPPES.
Does Dr. Rochelle Robicheaux Metoyer accept Medicare assignment?
Yes. Dr. Rochelle Robicheaux Metoyer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rochelle Robicheaux Metoyer commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.